Sarcopenia in Inflammatory Bowel Disease: A Narrative Overview

Overview

Journal Nutrients

Date 2021 Mar 6

PMID 33671473

Citations 44

Authors

Amritpal Dhaliwal

Jonathan I Quinlan

Kellie Overthrow

Carolyn Greig

Janet M Lord

Matthew J Armstrong

Sheldon C Cooper

Affiliations

Soon will be listed here.

Abstract

Malnutrition is a common condition encountered in patients with inflammatory bowel disease (IBD) and is often associated with sarcopenia (the reduction of muscle mass and strength) which is an ever-growing consideration in chronic diseases. Recent data suggest the prevalence of sarcopenia is 52% and 37% in Crohn's disease and ulcerative colitis, respectively, however it is challenging to fully appreciate the prevalence of sarcopenia in IBD. Sarcopenia is an important consideration in the management of IBD, including the impact on quality of life, prognostication, and treatment such as surgical interventions, biologics and immunomodulators. There is evolving research in many chronic inflammatory states, such as chronic liver disease and rheumatoid arthritis, whereby interventions have begun to be developed to counteract sarcopenia. The purpose of this review is to evaluate the current literature regarding the impact of sarcopenia in the management of IBD, from mechanistic drivers through to assessment and management.

Citing Articles

Bifidobacterium animalis subsp. lactis A6 ameliorates bone and muscle loss via modulating gut microbiota composition and enhancing butyrate production.

Chen M, Li Y, Zhai Z, Wang H, Lin Y, Chang F Bone Res. 2025; 13(1):28.

PMID: 40000617 PMC: 11862215. DOI: 10.1038/s41413-024-00381-1.

Preoperative Optimization of Crohn's Patients before Abdominopelvic Surgery.

Moussally M, Paski S, Cohen B, Holubar S Clin Colon Rectal Surg. 2025; 38(2):85-95.

PMID: 39944311 PMC: 11813612. DOI: 10.1055/s-0044-1786380.

Evaluating the role of sarcopenia in adverse clinical outcomes for Crohn's disease patients: a systematic review and meta-analysis.

Saleh O, Alshwayyat S, Hares M, Shalan S, Alasmar D, Alkurdi O Int J Colorectal Dis. 2025; 40(1):35.

PMID: 39934435 PMC: 11814033. DOI: 10.1007/s00384-025-04828-7.

Case report: A co-existing case of ulcerative colitis and dysferlinopathy in a male patient.

Li L, Yan Q, Deng M, Lu M, Zhou T, Zhong X Front Med (Lausanne). 2025; 11:1481780.

PMID: 39911674 PMC: 11794817. DOI: 10.3389/fmed.2024.1481780.

Assessment of body composition-related imaging parameters indicative of sarcopenia in Chinese patients with Crohn's disease: correlation with disease severity and biologic efficacy.

Xie C, Qian W, Shang L, Wang X, Zhang J, Ma X Am J Transl Res. 2024; 16(10):5427-5440.

PMID: 39544770 PMC: 11558411. DOI: 10.62347/ZPZR8134.

References

Dalle S, Rossmeislova L, Koppo K . The Role of Inflammation in Age-Related Sarcopenia. Front Physiol. 2018; 8:1045. PMC: 5733049. DOI: 10.3389/fphys.2017.01045. View

Gambero A, Marostica M, Saad M, Pedrazzoli Jr J . Mesenteric adipose tissue alterations resulting from experimental reactivated colitis. Inflamm Bowel Dis. 2007; 13(11):1357-64. DOI: 10.1002/ibd.20222. View

Loudon C, Corroll V, Butcher J, Rawsthorne P, Bernstein C . The effects of physical exercise on patients with Crohn's disease. Am J Gastroenterol. 1999; 94(3):697-703. DOI: 10.1111/j.1572-0241.1999.00939.x. View

DiFedele L, He J, Bonkowski E, Han X, Held M, Bohan A . Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis. Gastroenterology. 2005; 128(5):1278-91. DOI: 10.1053/j.gastro.2005.02.003. View

Bilski J, Mazur-Bialy A, Brzozowski B, Magierowski M, Zahradnik-Bilska J, Wojcik D . Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence. Pharmacol Rep. 2016; 68(4):827-36. DOI: 10.1016/j.pharep.2016.04.009. View

Ploeger H, Obeid J, Nguyen T, Takken T, Issenman R, de Greef M . Exercise and inflammation in pediatric Crohn's disease. Int J Sports Med. 2012; 33(8):671-9. DOI: 10.1055/s-0032-1304323. View

Smeuninx B, Greig C, Breen L . Amount, Source and Pattern of Dietary Protein Intake Across the Adult Lifespan: A Cross-Sectional Study. Front Nutr. 2020; 7:25. PMC: 7086014. DOI: 10.3389/fnut.2020.00025. View

OBrien S, Kavanagh R, Carey B, Maher M, OConnor O, Andrews E . The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease. Eur Radiol Exp. 2018; 2(1):37. PMC: 6246753. DOI: 10.1186/s41747-018-0072-3. View

Ni Lochlainn M, Bowyer R, Steves C . Dietary Protein and Muscle in Aging People: The Potential Role of the Gut Microbiome. Nutrients. 2018; 10(7). PMC: 6073774. DOI: 10.3390/nu10070929. View

10.

Zhang T, Ding C, Xie T, Yang J, Dai X, Lv T . Skeletal muscle depletion correlates with disease activity in ulcerative colitis and is reversed after colectomy. Clin Nutr. 2016; 36(6):1586-1592. DOI: 10.1016/j.clnu.2016.10.004. View

11.

Danese S, Vuitton L, Peyrin-Biroulet L . Biologic agents for IBD: practical insights. Nat Rev Gastroenterol Hepatol. 2015; 12(9):537-45. DOI: 10.1038/nrgastro.2015.135. View

12.

Coen P, Musci R, Hinkley J, Miller B . Mitochondria as a Target for Mitigating Sarcopenia. Front Physiol. 2019; 9:1883. PMC: 6335344. DOI: 10.3389/fphys.2018.01883. View

13.

Bryant R, Ooi S, Schultz C, Goess C, Grafton R, Hughes J . Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther. 2015; 41(9):895-906. DOI: 10.1111/apt.13156. View

14.

Robinson R, Krzywicki T, Almond L, Al-Azzawi F, Abrams K, Iqbal S . Effect of a low-impact exercise program on bone mineral density in Crohn's disease: a randomized controlled trial. Gastroenterology. 1998; 115(1):36-41. DOI: 10.1016/s0016-5085(98)70362-2. View

15.

Green B, Johnson C, Adams A . Writing narrative literature reviews for peer-reviewed journals: secrets of the trade. J Chiropr Med. 2009; 5(3):101-17. PMC: 2647067. DOI: 10.1016/S0899-3467(07)60142-6. View

16.

Frost R, Lang C . mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong?. Physiology (Bethesda). 2011; 26(2):83-96. PMC: 3606812. DOI: 10.1152/physiol.00044.2010. View

17.

Budui S, Rossi A, Zamboni M . The pathogenetic bases of sarcopenia. Clin Cases Miner Bone Metab. 2015; 12(1):22-6. PMC: 4469221. DOI: 10.11138/ccmbm/2015.12.1.022. View

18.

Olivier I, Theodorou V, Valet P, Castan-Laurell I, Guillou H, Bertrand-Michel J . Is Crohn's creeping fat an adipose tissue?. Inflamm Bowel Dis. 2010; 17(3):747-57. DOI: 10.1002/ibd.21413. View

19.

Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff S . ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2016; 36(1):49-64. DOI: 10.1016/j.clnu.2016.09.004. View

20.

Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T . Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology. 1998; 115(2):357-69. DOI: 10.1016/s0016-5085(98)70202-1. View